Free Trial
ASX:PCK

PainChek (PCK) Stock Price, News & Analysis

PainChek logo

About PainChek Stock (ASX:PCK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$50.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PainChek and its competitors with MarketBeat's FREE daily newsletter.

PCK Stock News Headlines

PainChek Ltd
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift
Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline.
PainChek Ltd.
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
ASX:PCK
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$8.31 million
Net Margins
-310.93%
Pretax Margin
N/A
Return on Equity
-653.62%
Return on Assets
-148.84%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.44
Quick Ratio
3.60

Sales & Book Value

Annual Sales
A$2.67 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,640,000,000
Free Float
N/A
Market Cap
A$50.62 million
Optionable
Not Optionable
Beta
0.74
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (ASX:PCK) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners